RT @YJanjigianMD: The next chapter in the epic story of HER2. Two trials in HER2+ BTC by @HardingJJMD @GABOUALFA & group. Data on 1) anti-…
62 followers
268 followers
RT @ucl_discovery: Open Access UCL Research: Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract can…
711 followers
RT @ucl_discovery: Open Access UCL Research: Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract can…
2,507 followers
Open Access UCL Research: Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study https://t.co/raWz5CaLBZ